Two Sigma Investments, LP Magenta Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.62 - $0.79 $17,915 - $22,827	28,896 Added 31.62%	120,269 $91,000
Q1 2023 May 15, 2023	SELL	$0.41 - $0.86 $38,848 - $81,486	-94,752 Reduced 50.91%	91,373 $72,000
Q4 2022 Feb 14, 2023	BUY	$0.36 - $1.59 $19,823 - $87,554	55,066 Added 42.02%	186,125 $74,000
Q3 2022 Nov 14, 2022	SELL	$1.26 - $2.09 $88,841 - $147,363	-70,509 Reduced 34.98%	131,059 $185,000
Q2 2022 Aug 15, 2022	BUY	$0.97 - $3.08 $42,436 - $134,746	43,749 Added 27.72%	201,568 $242,000
Q1 2022 May 16, 2022	SELL	$2.55 - $5.23 $45 - $94	-18 Reduced 0.01%	157,819 $458,000
Q4 2021 Feb 14, 2022	BUY	$4.43 - $8.33 $68,540 - $128,881	15,472 Added 10.87%	157,837 $699,000
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $174,160 - $283,763	-28,692 Reduced 16.77%	142,365 $1.04 Million
Q2 2021 Aug 16, 2021	BUY	$9.76 - $14.15 $124,586 - $180,624	12,765 Added 8.06%	171,057 $1.67 Million
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $307,855 - $537,742	-40,190 Reduced 20.25%	158,292 $1.87 Million
Q4 2020 Feb 16, 2021	BUY	$6.1 - $7.94 $69,045 - $89,872	11,319 Added 6.05%	198,482 $1.56 Million
Q3 2020 Nov 16, 2020	BUY	$6.52 - $8.94 $1.14 Million - $1.57 Million	175,563 Added 1513.47%	187,163 $1.27 Million
Q2 2020 Aug 14, 2020	SELL	$6.18 - $10.76 $34,175 - $59,502	-5,530 Reduced 32.28%	11,600 $87,000
Q1 2020 May 15, 2020	BUY	$6.03 - $15.24 $103,293 - $261,061	17,130 New	17,130 $108,000
Q1 2019 May 15, 2019	SELL	$5.7 - $19.7 $104,446 - $360,982	-18,324 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.57 - $11.65 $102,064 - $213,474	18,324 New	18,324 $104,000

Others Institutions Holding MGTA

# of Institutions

Shares Held

442K

Call Options Held

Put Options Held

Hellman Jordan Management CO Inc Quincy, MA

441K
Shares

$0
0.3% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.3K
Shares

$0
0.0% of portfolio

View Full List

About Magenta Therapeutics, Inc.

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

More about MGTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account